Get the Stockscreener App
42.88
1.22%
-0.53
After Hours:
43.43
0.55
+1.28%
Medline Inc stock is traded at $42.88, with a volume of 3.68M.
It is down -1.22% in the last 24 hours and down -5.32% over the past month.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
See More
Previous Close:
$43.41
Open:
$43.525
24h Volume:
3.68M
Relative Volume:
0.80
Market Cap:
$34.80B
Revenue:
$28.43B
Net Income/Loss:
$1.16B
P/E Ratio:
29.66
EPS:
1.4457
Net Cash Flow:
$1.26B
1W Performance:
-3.40%
1M Performance:
-5.32%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$42.65
$43.75
1-Week Range:
$42.53
$44.53
52-Week Range:
$38.50
$50.88
Medline Inc Stock (MDLN) Company Profile
Name
Medline Inc
Sector
Industry
Phone
847-949-3000
Address
3 LAKES DRIVE, NORTHFIELD
Compare MDLN vs ISRG, BDX, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDLN
Medline Inc
|
42.88 | 35.23B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
ISRG
Intuitive Surgical Inc
|
485.85 | 175.28B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
163.88 | 47.07B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
80.65 | 39.90B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
247.11 | 36.85B | 5.40B | 1.49B | 1.78B | 10.12 |
Medline Inc Stock (MDLN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-05-26 | Initiated | Tigress Financial | Buy |
| Jan-21-26 | Reiterated | BTIG Research | Buy |
| Jan-12-26 | Initiated | Citigroup | Buy |
| Jan-12-26 | Initiated | Deutsche Bank | Hold |
| Jan-12-26 | Initiated | Evercore ISI | Outperform |
| Jan-12-26 | Initiated | Goldman | Buy |
| Jan-12-26 | Initiated | JP Morgan | Overweight |
| Jan-12-26 | Initiated | Jefferies | Buy |
| Jan-12-26 | Initiated | Leerink Partners | Outperform |
| Jan-12-26 | Initiated | Mizuho | Outperform |
| Jan-12-26 | Initiated | Morgan Stanley | Overweight |
| Jan-12-26 | Initiated | Piper Sandler | Overweight |
| Jan-12-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-12-26 | Initiated | Robert W. Baird | Outperform |
| Jan-12-26 | Initiated | Rothschild & Co Redburn | Neutral |
| Jan-12-26 | Initiated | Stifel | Buy |
| Jan-12-26 | Initiated | TD Cowen | Buy |
| Jan-12-26 | Initiated | Truist | Buy |
| Jan-12-26 | Initiated | UBS | Buy |
| Jan-12-26 | Initiated | Wells Fargo | Equal Weight |
| Jan-12-26 | Initiated | William Blair | Outperform |
| Jan-12-26 | Initiated | Wolfe Research | Outperform |
View All
Medline Inc Stock (MDLN) Latest News
Medline (MDLN) Q4 net sales rise 14.8% to $7.8B following completion of IPO - MSN
Medline (MDLN) Q4 Net Sales Rise 14.8% to $7.8B Following Completion of IPO - Insider Monkey
Medline Awards Distribution Center of the Year and SAFE Awards - marketscreener.com
Medline stock price target raised to $60 by Tigress Financial - Investing.com
Medline prices $3B secondary offering at $41 per share - MSN
Medline stock price target reaffirmed at $55 by BTIG - Investing.com
Medline Inc. announces pricing of secondary offering of class A common stock - Sahm
Medline’s buyout firm backers raise $3.1B in share sale - Crain's Chicago Business
Medline’s PE owners cash out US$3.1bn in early lockup release - ifre.com
Medline Secondary Common Stock Offering Prices; Shares Down Pre-Bell - marketscreener.com
Medline stockholders price secondary offering at $41 per share By Investing.com - Investing.com Australia
Medline stockholders price secondary offering at $41 per share - Investing.com
Medline’s Buyout Firm Backers Raise $3.1 Billion in Share Sale - Bloomberg.com
Medline Inc. Announces Pricing Of Secondary Offering Of Class A Common Stock - TradingView
Shareholders of the American Medline intend to sell shares worth $ 3.4 billion - AKM.RU
Ear Syringe Market Set to Witness Rapid Growth Through 2033 | - openPR.com
Medline Backers Launch $3.4B Secondary Sale Near Chicago - Hoodline
Blackstone, Carlyle, Hellman & Friedman Offer 75M Shares For MedlineMedline (NASDAQ:MDLN) - Benzinga
Medline’s PE backers start stake sale worth $3.4 billion - Crain's Chicago Business
Medline Shareholders Seek $3.4 Billion Stake Sale - Transport Topics
Medline’s PE Backers Start Stake Sale Worth $3.4 Billion - Bloomberg
Medline stockholders launch 75 million share offering - Investing.com
Medline shares fall 4.4% as major investors launch secondary offering By Investing.com - Investing.com Nigeria
Medline stockholders launch 75 million share offering By Investing.com - Investing.com Canada
Medline announces $3.6B secondary offering from private equity firms - MassDevice
Medline Inc. announces launch of secondary offering of Class A common stock - GlobeNewswire
Form S-1 Medline Inc. - StreetInsider
USA Herald - USA Herald
The 20+ Club: Ron Woosley - Medline Newsroom
Medline expands AI platform and warehouse robotics - Digital Commerce 360
Medline Inc.: Fundamental Analysis and Financial Ratings | MDLN | US58507V1070 - marketscreener.com
The Analyst Verdict: Medline In The Eyes Of 29 Experts - Benzinga
Wells Fargo & Company Increases Medline (NASDAQ:MDLN) Price Target to $47.00 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Medline, Inc. Class A (MDLN) and Silence Therapeutics (SLN) - The Globe and Mail
Medline Inc (MDLN) Q4 2025 Earnings Call Highlights: Record Sales and Strategic Innovations ... By GuruFocus - Investing.com Canada
Medline Analysts Boost Their Forecasts Following Q4 Results - Benzinga
Medline (NASDAQ:MDLN) Given New $54.00 Price Target at BMO Capital Markets - MarketBeat
Medline boasts $2.4B in new customer signings in 2025 - HME News
Wolfe Research raises Medline stock price target on revenue beat By Investing.com - Investing.com India
Wolfe Research raises Medline stock price target on revenue beat - Investing.com
CEO of Northfield-based Medline talks tariffs, IPO following company’s first earnings call - Chicago Tribune
Analyst recommendations: Spotify, Gartner, Godaddy, Medline, Moderna… - marketscreener.com
Evercore ISI Maintains Outperform on Medline Inc (MDLN) Feb 25 2026 - Meyka
Medline's first quarter as a public company ends with rising sales, dip in income - Crain's Chicago Business
Medline Inc. SEC 10-K Report - TradingView
Stifel raises Medline stock price target to $55 on strong results - Investing.com
Medline Q4 Earnings Call Highlights - MarketBeat
Evercore ISI raises Medline stock price target on strong momentum By Investing.com - Investing.com South Africa
Evercore ISI raises Medline stock price target on strong momentum - Investing.com
Robust Q4 Beat and Underappreciated 2026 Upside Support Buy Rating on Medline - TipRanks
Medline Inc Stock (MDLN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):